Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 5/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.40 |
| ▸ | MPL | P40238 | 3/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16414055 | 0.89 | MPL (0.44) | ALDH1A1L3MBTL1HSD11B1NOTUMMPL | |
| SCHEMBL397945 | 0.85 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1HSD11B1HSD17B10NOTUM | |
| SCHEMBL4392002 | 0.84 | PDK2 (0.42) | ALDH1A1L3MBTL1HSD11B1HSD17B10NOTUM | |
| SCHEMBL29589903 | 0.81 | CD44 (0.42) | ALDH1A1L3MBTL1HSD17B10MPLPDK2 | |
| SCHEMBL476347 | 0.81 | CD44 (0.42) | ALDH1A1L3MBTL1HSD17B10MPLPDK2 | |
| SCHEMBL3791451 | 0.80 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1HSD11B1HSD17B10MPL | |
| SCHEMBL3790614 | 0.80 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1HSD11B1HSD17B10MPL | |
| SCHEMBL27083623 | 0.79 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1HSD11B1HSD17B10NOTUM | |
| SCHEMBL28527850 | 0.78 | TSHR (0.39) | ALDH1A1L3MBTL1HSD17B10MPLPDK2 | |
| SCHEMBL11654081 | 0.78 | ALDH1A1 (0.77) | ALDH1A1L3MBTL1HSD17B10TDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3467041-B1 | HIGH-STRENGTH TRANSPARENT POLYAMIDIMIDE AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD (KR) | 2020-12-09 | — | — | EP | claimed |
| CN-101440037-A | 3,3'-dibromo-4,4',6,6'-tetra(trifluoromethyl)biphenyl-2,2'-diamine and preparation thereof | UNIV WUHAN (CN) | 2009-05-27 | — | — | CN | claimed |
| CN-114940661-B | Camphora-reducing derived [2, 1] -bridged cyclic enones compound and synthesis method and application thereof | 武汉大学 | 2023-12-22 | — | — | CN | disclosed |
| CN-110577485-B | Norcamphor derived [2, 1] -bridged ring ketene compounds and synthesis method and application thereof | 武汉大学 | 2022-11-04 | — | — | CN | disclosed |
| CN-114940661-A | Norcamphor derived [2,2,1] -bridged ketene compounds and synthesis method and application thereof | 武汉大学 | 2022-08-26 | — | — | CN | disclosed |
| CN-110577485-A | Norcamphor derived [2,2,1] -bridged ketene compounds and synthesis method and application thereof | 武汉大学 | 2019-12-17 | — | — | CN | disclosed |
| CN-101440037-B | 3,3'-dibromo-4,4',6,6'-tetra(trifluoromethyl)biphenyl-2,2'-diamine and preparation thereof | UNIV WUHAN | 2012-02-29 | — | — | CN | disclosed |
| CN-101333230-B | Phosphoramidite type diphosphine ligand, preparation method and application thereof | UNIV WUHAN | 2010-12-22 | — | — | CN | disclosed |
| CN-101200440-B | Enantiopure 4,4',6,6'-tetrakis (trifluorome-thyl)-biphenyl -2,2'-diamine as well as intermediate and preparation method thereof | UNIV WUHAN | 2010-12-01 | — | — | CN | disclosed |
| CN-101200440-B | Enantiopure 4,4',6,6'-tetrakis (trifluorome-thyl)-biphenyl -2,2'-diamine as well as intermediate and preparation method thereof | UNIV WUHAN | 2010-12-01 | — | — | CN | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| CN-101333230-A | Phosphoramidite type diphosphine ligand, preparation method and application thereof | UNIV WUHAN (CN) | 2008-12-31 | — | — | CN | disclosed |
| CN-101200440-A | Enantiopure 4,4',6,6'-tetrakis (trifluorome-thyl)-biphenyl -2,2'-diamine as well as intermediate and preparation method thereof | UNIV WUHAN (CN) | 2008-06-18 | — | — | CN | disclosed |
| CN-101200440-A | Enantiopure 4,4',6,6'-tetrakis (trifluorome-thyl)-biphenyl -2,2'-diamine as well as intermediate and preparation method thereof | UNIV WUHAN (CN) | 2008-06-18 | — | — | CN | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| EP-1141092-A1 | IMIDE CONTAINING POLYMERS MADE BY BULK POLYMERIZATION | Sumitomo Bakelite Company Limited (JP) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026277-A1 | IMIDE CONTAINING POLYMERS MADE BY BULK POLYMERIZATION | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | ALDH1A1 4339/4885L3MBTL1 3838/4885HSD11B1 1153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.